This inventor holds 1 USPTO granted patent. Top assignee: Smithkline Beecham Corporation. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Chanal Myriam Petit: Innovator in Antibacterial Research
Introduction
Chanal Myriam Petit is a notable inventor based in Wayne, PA (US). He has made significant contributions to the field of antibacterial research through his innovative work. His expertise and dedication have led to the development of valuable inventions that aim to combat bacterial infections.
Latest Patents
Chanal Myriam Petit holds a patent for "Phosphatidylglycerophosphate synthase from Staphylococcus aureus." This invention provides Phosphatidylglycerophosphate Synthase polypeptides, also known as pgsA polypeptides. The patent outlines methods for utilizing these pgsA polypeptides to screen for antibacterial compounds, showcasing his commitment to advancing medical science.
Career Highlights
Chanal is currently employed at SmithKline Beecham Corporation, where he continues to apply his knowledge and skills in the field of research and development. His work at the company has allowed him to focus on innovative solutions to pressing health issues.
Collaborations
Chanal has collaborated with esteemed colleagues, including David John Holmes and Christopher Michael Traini. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.
Conclusion
Chanal Myriam Petit is a dedicated inventor whose work in antibacterial research is making a significant impact. His innovative patent and collaborations highlight his commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile